Director/PDMR Shareholding

RNS Number : 1909I

Hikma Pharmaceuticals Plc

19 March 2018

 

Hikma Pharmaceuticals PLC - EIP Awards

LONDON, 19 March 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 17 March 2016 under the 2014 Executive Incentive Plan ("EIP") which was completed on 19 March 2018. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the EIP is £nil.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 19 March 2018 under the 2014 EIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 68,346
d)	Aggregated information	N/A
e)	Date of the transaction	19 March 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 19 March 2018 under the 2014 EIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 38,501
d)	Aggregated information	N/A
e)	Date of the transaction	19 March 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Bassam Kanaan

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 19 March 2018 under the 2014 EIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 26,090
d)	Aggregated information	N/A
e)	Date of the transaction	19 March 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 19 March 2018 under the 2014 EIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 20,400
d)	Aggregated information	N/A
e)	Date of the transaction	19 March 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Majda Labadi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Majda Labadi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from vesting of the conditional awards on 19 March 2018 under the 2014 EIP.
c)	Price(s) and volume(s)	Price(s): £nil Volume(s): 14,530
d)	Aggregated information	N/A
e)	Date of the transaction	19 March 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

 

END

 

 

DSHBUGDXCSBBGIC